These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8761081)

  • 1. [Xeroderma pigmentosum. A study in 40 Algerian patients].
    Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
    Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients.
    Daya-Grosjean L; Robert C; Drougard C; Suarez H; Sarasin A
    Cancer Res; 1993 Apr; 53(7):1625-9. PubMed ID: 8453633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
    Daya-Grosjean L; Sarasin A
    Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
    Suarez HG; Daya-Grosjean L; Schlaifer D; Nardeux P; Renault G; Bos JL; Sarasin A
    Cancer Res; 1989 Mar; 49(5):1223-8. PubMed ID: 2645047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.
    Sato M; Nishigori C; Zghal M; Yagi T; Takebe H
    Cancer Res; 1993 Jul; 53(13):2944-6. PubMed ID: 8319200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes.
    Dumaz N; Duthu A; Ehrhart JC; Drougard C; Appella E; Anderson CW; May P; Sarasin A; Daya-Grosjean L
    Mol Carcinog; 1997 Dec; 20(4):340-7. PubMed ID: 9433478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts.
    Evans MK; Taffe BG; Harris CC; Bohr VA
    Cancer Res; 1993 Nov; 53(22):5377-81. PubMed ID: 8221675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated oncogenes in human tumors.
    Suárez HG
    Anticancer Res; 1989; 9(5):1331-43. PubMed ID: 2686533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
    Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
    Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
    Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
    Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.
    de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H
    Oncogene; 1998 Apr; 16(17):2205-12. PubMed ID: 9619829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strand specificity and absence of hot spots for p53 mutations in ultraviolet B-induced skin tumors of XPA-deficient mice.
    Takeuchi S; Nakatsu Y; Nakane H; Murai H; Hirota S; Kitamura Y; Okuyama A; Tanaka K
    Cancer Res; 1998 Feb; 58(4):641-6. PubMed ID: 9485015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
    Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
    Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum].
    Mimaki T; Tanaka K; Nagai A; Mino M
    Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurological abnormalities in xeroderma pigmentosum].
    El Fékih N; Fredj M; Aounallah-Skhiri H; Fazaa B; Zghal M; Ridha Kamoun M
    Rev Neurol (Paris); 2009 Nov; 165(11):967-70. PubMed ID: 19268336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study.
    Bhutto AM; Shaikh A; Nonaka S
    Br J Dermatol; 2005 Mar; 152(3):545-51. PubMed ID: 15787826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient.
    Williams C; Pontén F; Ahmadian A; Ren ZP; Ling G; Rollman O; Ljung A; Jaspers NG; Uhlén M; Lundeberg J; Pontén J
    Cancer Res; 1998 Jun; 58(11):2449-55. PubMed ID: 9622088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.